This sequential development of lesions was leveraged by testing the hypothesis that introduction of the mutant PNPLA3 I148M variant but not the wild type PNPLA3 fed this diet would accelerate the disease and lead to steatohepatitis and fibrosis at a time point where mice with empty vector would only have steatosis. This evidence concerns the gene PNPLA3 and steatosis.